What To Know Before Buying Stock?: BioNTech SE, (NASDAQ: BNTX)

 

On Monday, November 16, 2020, the Company, BioNTech SE, BNTX stock construct a change of -13.66 percent (Loss) in a total of its share price and having its trading value $91.52, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $21.13B with the total Outstanding Shares of 238.67M.

 


P/S, P/E, P/B & P/C values of (NASDAQ: BNTX):

 

BioNTech SE institutional ownership is standing at 12 percent, while insider ownership is 1.18 percent. As of now, BNTX has a P/S, P/E and, P/B values of 0, 0, and 19.94 respectively. Its P/Cash is valued at 17.75.

 

The stock SMA50 is now at 13.03 percent. In looking, the SMA 200 we see that the stock has seen a 49.34 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 0 percent.


Profitability ratios:

 

Looking into the profitability ratios of BNTX stock, an investor will find its ROE, ROA, ROI standing at 0 percent, 0 percent and, -31.4 percent, respectively.


Beta Factor:

 

A beta factor is used to measure the volatility of the stock. The stock remaining at 6.61 percent volatile for the week and 6.5 percent for the month.


Gross / Operating Margins of BNTX:

 

It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 0 percent & Operating Margin seen at 0 percent.


Target Price:

 

Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company BioNTech SE recorded it at $102.92.


Historical Performance In The News:

 

Taking a look at the performance of BioNTech SE stock, an investor will come to know that the weekly performance for this stock is valuing at -12.67 percent, resulting in a performance for the month at -2.73 percent.

Therefore, the stated figure displays a quarterly performance of 34.83 percent, bringing six-month performance to 80.91 percent and year to date performance of 170.13 percent. As of now, BioNTech SE has a P/S, P/E and, P/B values of 0, 0, and 19.94 respectively. Its P/Cash is valued at 17.75.


Earnings per Share Details of BioNTech SE:

 

The EPS of BNTX is strolling at 0, measuring its EPS growth this year at -300.5 percent. As a result, the company has an EPS growth of 2946.3 percent for the approaching year.